Phenylpiperazine derivatives synthesized at SCRAS claimed for BPH, portal hypertension, cirrhosis Nov. 8, 2001
U.S. phase III efficacy and safety data for Foznol discussed at World Congress of Nephrology Oct. 19, 2001